Search - tctmd.com

Displaying 161 - 180 of 367

Sort: Relevancy | Date

Presentation SOLACI 2017

Role of Embolic Protection during TAVR

Presenter: Samir Kapadia

August 02, 2017

Presentation TVT 2017

Are TMVR Devices Implantable in the Tricuspid Position?

Presenter: Neil E. Moat, Samir R. Kapadia

June 16, 2017

Presentation TVT 2017

Tendyne

Presenter: Francesco Maisano, Samir R. Kapadia

June 16, 2017

Presentation TVT 2017

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Presenter: Samir R. Kapadia

June 16, 2017

Presentation TVT 2017

The TAVR Stroke Manifesto Changing Frequency, Comparison With SAVR, Diagnosis and Treatment in the Modern Era, and Use of Cerebral Protection

Presenter: Axel Linke, Jeffrey J. Popma, Samir R. Kapadia

June 15, 2017

News Daily News

FDA Clears Sentinel Cerebral Protection Device for Use During TAVR

Shelley Wood

June 05, 2017

News Industry News

NaviGate Cardiac Structures, Inc. (“NCSI”) reports first heterotopic transcatheter GATE™ tricuspid valved stent successful implantation

April 26, 2017

News Daily News

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

L.A. McKeown

April 12, 2017

News Daily News

MitraClip for Tricuspid Regurgitation Gains Traction but Still in Preliminary Stages

Yael L. Maxwell

March 27, 2017

Presentation SIF 2017

Valve-in-Valve: What You Need to Know

Presenter: Samir Kapadia

March 11, 2017

Presentation SIF 2017

Best Practices: Sapien 3

Presenter: Samir Kapadia

March 11, 2017

Presentation SIF 2017

Thromboembolic Prophylaxis in Atrial Fibrillation

Presenter: Samir Kapadia

March 09, 2017

Presentation SIF 2017

Guidelines in Choosing Optimal Patient For Watchman

Presenter: Samir Kapadia

March 09, 2017

News Daily News

LAA Thrombus Explored as Potential Cause of Stroke After TAVR

Todd Neale

January 16, 2017

News Features

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Shelley Wood

December 30, 2016

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Features

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

Shelley Wood

December 30, 2016

News Industry News

Cardiac Dimensions Announces Investigational Device Exemption Approval from FDA to Conduct U.S. Pivotal Study of the Carillon Mitral Contour System for Functional Mitral Regurgitation

December 01, 2016

Presentation TCT 2016

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Presenter: Martin W. Bergmann, Samir R. Kapadia, Vivek Y. Reddy

November 01, 2016

Presentation TCT 2016

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Presenter: Martin W. Bergmann, Samir R. Kapadia, Harvey D. White

November 01, 2016

Advertisement

Role of Embolic Protection during TAVR

Are TMVR Devices Implantable in the Tricuspid Position?

Tendyne

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

The TAVR Stroke Manifesto Changing Frequency, Comparison With SAVR, Diagnosis and Treatment in the Modern Era, and Use of Cerebral Protection

FDA Clears Sentinel Cerebral Protection Device for Use During TAVR

NaviGate Cardiac Structures, Inc. (“NCSI”) reports first heterotopic transcatheter GATE™ tricuspid valved stent successful implantation

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

MitraClip for Tricuspid Regurgitation Gains Traction but Still in Preliminary Stages

Valve-in-Valve: What You Need to Know

Best Practices: Sapien 3

Thromboembolic Prophylaxis in Atrial Fibrillation

Guidelines in Choosing Optimal Patient For Watchman

LAA Thrombus Explored as Potential Cause of Stroke After TAVR

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más

Cardiac Dimensions Announces Investigational Device Exemption Approval from FDA to Conduct U.S. Pivotal Study of the Carillon Mitral Contour System for Functional Mitral Regurgitation

Is Ablation an Alternative to Triple Therapy in Patients With Atrial Fibrillation and PCI or ACS?

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content